HOME
MARKET
TRADE
PRICING
PLATFORM
HELP
LOG IN
EU's CHMP Recommends Conditional Marketing Authorization For Roche's Polivy To Treat Relapsed, Refractory Diffuse Large B-Cell Lymphoma; Separately Reports Marketing Authorization For Novartis' Isturisa
-Reuters
Reuters · 11/15/2019 11:33
Related